Leads Biolabs is developing LBL-047, a new bispecific antibody for autoimmune diseases that targets B cells and pDCs. LBL-047 ...
Drug-resistant tuberculosis remains one of the most persistent infectious disease threats, driven in large part by ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果